Funder
National Taiwan University College of Medicine
College of Medicine, Catholic University of Korea
National Science and Technology Council
Ministry of Science and Technology, Taiwan
National Taiwan University
Reference28 articles.
1. World Health Organization. COVID-19 Landscape of novel coronavirus candidate vaccine development worldwide. Available from: https://www.who.int/publications/m/item/draft-landscape-of-covid-19-candidate-vaccines. Accessed February 2, 2023.
2. Safety, reactogenicity and immunogenicity of homologous and heterologous prime-boost immunization with ChAdOx1-nCoV19 and BNT162b2: a prospective cohort study;Hillus;Lancet Respir Med,2021
3. Heterologous ChAdOx1 nCoV-19 and mRNA-1273 vaccination;Normark;N Engl J Med,2021
4. Immune response and safety of heterologous ChAdOx1-nCoV-19/mRNA-1273 vaccination compared with homologous ChAdOx1-nCoV-19 or homologous mRNA-1273 vaccination;Sheng;J Formos Med Assoc,2022
5. Safety and immunogenicity of seven COVID-19 vaccines as a third dose (booster) following two doses of ChAdOx1 nCov-19 or BNT162b2 in the UK (COV-BOOST): a blinded, multicentre, randomized, controlled, phase 2 trial;Munro;Lancet,2021